IS2551B - 2-(1H-indólýlsúlfanýl)-bensýl amín afleiður sem valvís serótónín endurupptöku hindri (SSRI) - Google Patents
2-(1H-indólýlsúlfanýl)-bensýl amín afleiður sem valvís serótónín endurupptöku hindri (SSRI)Info
- Publication number
- IS2551B IS2551B IS8467A IS8467A IS2551B IS 2551 B IS2551 B IS 2551B IS 8467 A IS8467 A IS 8467A IS 8467 A IS8467 A IS 8467A IS 2551 B IS2551 B IS 2551B
- Authority
- IS
- Iceland
- Prior art keywords
- indolylsulfanyl
- ssri
- serotonin reuptake
- reuptake inhibitor
- amine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200301923 | 2003-12-23 | ||
| PCT/DK2004/000894 WO2005061455A1 (en) | 2003-12-23 | 2004-12-21 | 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IS8467A IS8467A (is) | 2006-05-15 |
| IS2551B true IS2551B (is) | 2009-10-15 |
Family
ID=36603121
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS8467A IS2551B (is) | 2003-12-23 | 2006-05-15 | 2-(1H-indólýlsúlfanýl)-bensýl amín afleiður sem valvís serótónín endurupptöku hindri (SSRI) |
| IS8827A IS2815B (is) | 2003-12-23 | 2009-06-05 | 2-(1H-indólýlsúlfanýl)-bensýlamínafleiður sem valvís serótónín endurupptökuhindri (SSRI). |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS8827A IS2815B (is) | 2003-12-23 | 2009-06-05 | 2-(1H-indólýlsúlfanýl)-bensýlamínafleiður sem valvís serótónín endurupptökuhindri (SSRI). |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1860100B1 (is) |
| KR (2) | KR100872022B1 (is) |
| CN (2) | CN100591666C (is) |
| AR (1) | AR046978A1 (is) |
| AT (1) | ATE500220T1 (is) |
| CA (1) | CA2551168C (is) |
| DE (1) | DE602004031680D1 (is) |
| DK (1) | DK1860100T3 (is) |
| EA (2) | EA010666B1 (is) |
| ES (1) | ES2362237T3 (is) |
| HK (1) | HK1103075A1 (is) |
| IS (2) | IS2551B (is) |
| ME (1) | ME01040B (is) |
| MY (1) | MY143038A (is) |
| NO (1) | NO336676B1 (is) |
| NZ (1) | NZ547046A (is) |
| PL (1) | PL1860100T4 (is) |
| PT (1) | PT1860100E (is) |
| RS (1) | RS51899B (is) |
| SG (1) | SG141463A1 (is) |
| SI (1) | SI1860100T1 (is) |
| TW (1) | TWI347183B (is) |
| UA (1) | UA82920C2 (is) |
| ZA (1) | ZA200705870B (is) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101224201B (zh) * | 2007-01-18 | 2011-10-05 | 和泓生物技术（上海）有限公司 | 多巴胺转运蛋白和去甲肾上腺素转运蛋白双重抑制剂的应用 |
| EP2606031B1 (en) * | 2010-08-20 | 2017-09-27 | Amira Pharmaceuticals, Inc. | Autotaxin inhibitors and uses thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3803143A (en) | 1969-09-08 | 1974-04-09 | Eisai Co Ltd | 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines |
| US4018830A (en) | 1969-09-22 | 1977-04-19 | Merck & Co., Inc. | Phenylthioaralkylamines |
| US4055665A (en) | 1974-11-25 | 1977-10-25 | Merck & Co., Inc. | Treating arrythmia with phenylthioaralkylamines |
| US4056632A (en) | 1975-07-21 | 1977-11-01 | Burroughs Wellcome Co. | 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use |
| EP0396827A1 (en) | 1989-05-09 | 1990-11-14 | SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu | 2-Phenylthiobenzylamine dervivatives and acid addition salts thereof |
| GB8912971D0 (en) | 1989-06-06 | 1989-07-26 | Wellcome Found | Halogen substituted diphenylsulfides |
| GB9126311D0 (en) | 1991-12-11 | 1992-02-12 | Wellcome Found | Substituted diphenylsulfides |
| CZ293595A3 (cs) | 1995-11-09 | 1999-12-15 | Farmak A. S. | Deriváty N,N-dimethyl-2-(arylthio)benzylaminu, jejich soli, způsoby jejich přípravy a jejich použití v léčivých přípravcích |
| US5912256A (en) * | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
| DE69719765T2 (de) * | 1996-08-27 | 2003-10-16 | Wyeth Corp | 4-aminoethoxy-indolderivate als dopamin d2 agonisten und als 5ht1a liganden |
| ES2264259T3 (es) | 1999-04-30 | 2006-12-16 | Trustees Of The University Of Pennsylvania | Agentes de obtencion de imagenes por spect (tomografia por emision de foton unico) para transportador de serotonina. |
| US6410736B1 (en) | 1999-11-29 | 2002-06-25 | Pfizer Inc. | Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| US6436938B1 (en) | 2001-01-22 | 2002-08-20 | Pfizer Inc. | Combination treatment for depression |
-
2004
- 2004-12-16 TW TW093139107A patent/TWI347183B/zh not_active IP Right Cessation
- 2004-12-21 EP EP07017638A patent/EP1860100B1/en active Active
- 2004-12-21 NZ NZ547046A patent/NZ547046A/en not_active IP Right Cessation
- 2004-12-21 UA UAA200607149A patent/UA82920C2/uk unknown
- 2004-12-21 SI SI200431671T patent/SI1860100T1/sl unknown
- 2004-12-21 KR KR1020067011175A patent/KR100872022B1/ko active IP Right Grant
- 2004-12-21 CN CN200480038470A patent/CN100591666C/zh not_active Expired - Fee Related
- 2004-12-21 CN CNA2008101447939A patent/CN101372474A/zh active Pending
- 2004-12-21 MY MYPI20045285A patent/MY143038A/en unknown
- 2004-12-21 ME MEP-2008-66A patent/ME01040B/me unknown
- 2004-12-21 PT PT07017638T patent/PT1860100E/pt unknown
- 2004-12-21 DE DE602004031680T patent/DE602004031680D1/de active Active
- 2004-12-21 ZA ZA200705870A patent/ZA200705870B/xx unknown
- 2004-12-21 PL PL07017638T patent/PL1860100T4/pl unknown
- 2004-12-21 SG SG200802454-9A patent/SG141463A1/en unknown
- 2004-12-21 CA CA2551168A patent/CA2551168C/en not_active Expired - Fee Related
- 2004-12-21 RS RS20110213A patent/RS51899B/en unknown
- 2004-12-21 EA EA200601226A patent/EA010666B1/ru not_active IP Right Cessation
- 2004-12-21 DK DK07017638.3T patent/DK1860100T3/da active
- 2004-12-21 ES ES07017638T patent/ES2362237T3/es active Active
- 2004-12-21 KR KR1020087021534A patent/KR20080092471A/ko not_active Application Discontinuation
- 2004-12-21 AT AT07017638T patent/ATE500220T1/de active
- 2004-12-21 EA EA200702258A patent/EA012752B1/ru not_active IP Right Cessation
- 2004-12-21 AR ARP040104830A patent/AR046978A1/es not_active Application Discontinuation
-
2006
- 2006-05-15 IS IS8467A patent/IS2551B/is unknown
- 2006-07-24 NO NO20063405A patent/NO336676B1/no not_active IP Right Cessation
-
2007
- 2007-07-13 HK HK07107553.7A patent/HK1103075A1/xx not_active IP Right Cessation
-
2009
- 2009-06-05 IS IS8827A patent/IS2815B/is unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS7164A (is) | Fenýl-píperasín afleiður sem serótónín endurupptökuhindrar | |
| EE200300478A (et) | Tsüklopropüülindooli derivaadid kui selektiivsed serotoniini tagasihaarde inhibiitorid | |
| DK1848430T3 (da) | Nye benzylamin-derivativer som cetp-inhibitors | |
| DK1638933T3 (da) | N-pyrrolidin-3-yl-amid-derivater som serotonin- og noradrenalin-genoptagelses inhibitorer | |
| DK1789041T3 (da) | Aryl-pyridinderivater som 11-beta-HSD1-inhibitorer | |
| DK1797042T3 (da) | Indozolonderivater som 11B-HSD1-inhibitorer | |
| ATE478049T1 (de) | Phosphodiesterase-4-inhibitoren, einschliesslich n-substituierter diarylaminanaloga | |
| IL179371A0 (en) | 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor | |
| EE200300084A (et) | Fenoksübensüülamiini derivaadid kui selektiivsed serotoniini tagasihaarde inhibiitorid | |
| GB0314054D0 (en) | Amide derivatives as selective serotonin re-uptake inhibitors | |
| DK1511718T3 (da) | N-acylaminobenzenderivater som selektive monoaminoxidase B-inhibitorer | |
| EE200300498A (et) | Fenüül-heterotsüklüüleetri derivaadid kui serotoniini tagasihaarde inhibiitorid | |
| PL1710240T3 (pl) | Pochodne piperazyny i ich zastosowanie jako inhibitorów ponownego wychwytu serotoniny lub jako antagonistów neurokininy | |
| IS2551B (is) | 2-(1H-indólýlsúlfanýl)-bensýl amín afleiður sem valvís serótónín endurupptöku hindri (SSRI) | |
| HK1095135A1 (en) | Morpholine derivatives as norepinephrine reuptake inhibitors | |
| IS7996A (is) | 4-(2-fenýlsúlfanýl-fenýl)-píperidín afleiður sem serótónín endurupptöku hindrar | |
| DK1377550T3 (da) | Phenyl-heterocyclyletherderivater som serotonin-re-uptakeinhibitorer |